CN116270903A - Yi medicine Jin Lingqing pharyngeal granules and preparation method thereof - Google Patents
Yi medicine Jin Lingqing pharyngeal granules and preparation method thereof Download PDFInfo
- Publication number
- CN116270903A CN116270903A CN202111490521.6A CN202111490521A CN116270903A CN 116270903 A CN116270903 A CN 116270903A CN 202111490521 A CN202111490521 A CN 202111490521A CN 116270903 A CN116270903 A CN 116270903A
- Authority
- CN
- China
- Prior art keywords
- nationality
- parts
- medicine
- granules
- minutes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 53
- 239000008187 granular material Substances 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title abstract description 17
- 244000246386 Mentha pulegium Species 0.000 claims abstract description 23
- 235000016257 Mentha pulegium Nutrition 0.000 claims abstract description 23
- 235000004357 Mentha x piperita Nutrition 0.000 claims abstract description 23
- 235000001050 hortel pimenta Nutrition 0.000 claims abstract description 23
- 235000014676 Phragmites communis Nutrition 0.000 claims abstract description 22
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 20
- 235000002226 Ranunculus ficaria Nutrition 0.000 claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 13
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract 4
- 238000010992 reflux Methods 0.000 claims description 57
- 239000007788 liquid Substances 0.000 claims description 48
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 34
- 239000000463 material Substances 0.000 claims description 33
- 229930006000 Sucrose Natural products 0.000 claims description 32
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 32
- 239000005720 sucrose Substances 0.000 claims description 32
- 239000000843 powder Substances 0.000 claims description 30
- 239000002245 particle Substances 0.000 claims description 26
- 239000000203 mixture Substances 0.000 claims description 25
- 238000001914 filtration Methods 0.000 claims description 22
- 241001269715 Laggera pterodonta Species 0.000 claims description 18
- 241001530126 Scrophularia Species 0.000 claims description 17
- 238000001035 drying Methods 0.000 claims description 17
- 239000004375 Dextrin Substances 0.000 claims description 16
- 229920001353 Dextrin Polymers 0.000 claims description 16
- 238000009835 boiling Methods 0.000 claims description 16
- 235000019425 dextrin Nutrition 0.000 claims description 16
- 239000003651 drinking water Substances 0.000 claims description 16
- 235000020188 drinking water Nutrition 0.000 claims description 16
- 239000000284 extract Substances 0.000 claims description 16
- 239000007779 soft material Substances 0.000 claims description 16
- 239000000706 filtrate Substances 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 9
- 238000002791 soaking Methods 0.000 claims description 9
- 239000004677 Nylon Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 229920001778 nylon Polymers 0.000 claims description 8
- 238000004806 packaging method and process Methods 0.000 claims description 8
- 239000008213 purified water Substances 0.000 claims description 8
- 229910001220 stainless steel Inorganic materials 0.000 claims description 8
- 239000010935 stainless steel Substances 0.000 claims description 8
- 230000007306 turnover Effects 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 6
- 244000170916 Paeonia officinalis Species 0.000 claims 3
- 201000007100 Pharyngitis Diseases 0.000 abstract description 31
- 230000000694 effects Effects 0.000 abstract description 19
- 241001106477 Paeoniaceae Species 0.000 abstract description 16
- 206010068319 Oropharyngeal pain Diseases 0.000 abstract description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 6
- 208000026435 phlegm Diseases 0.000 abstract description 6
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 5
- 230000003078 antioxidant effect Effects 0.000 abstract description 4
- 230000000845 anti-microbial effect Effects 0.000 abstract description 3
- 239000012084 conversion product Substances 0.000 abstract description 3
- 238000001784 detoxification Methods 0.000 abstract description 3
- 238000000354 decomposition reaction Methods 0.000 abstract description 2
- 238000001727 in vivo Methods 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 241000293861 Scrophularia nodosa Species 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 36
- 239000000047 product Substances 0.000 description 26
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
- 241001570521 Lonicera periclymenum Species 0.000 description 21
- 239000008280 blood Substances 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 15
- 230000009471 action Effects 0.000 description 13
- 239000013558 reference substance Substances 0.000 description 12
- 238000001816 cooling Methods 0.000 description 11
- 235000019441 ethanol Nutrition 0.000 description 10
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- 230000001276 controlling effect Effects 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 230000000144 pharmacologic effect Effects 0.000 description 7
- 235000019640 taste Nutrition 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 6
- 229940088710 antibiotic agent Drugs 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 238000004809 thin layer chromatography Methods 0.000 description 6
- 231100000331 toxic Toxicity 0.000 description 6
- 230000002588 toxic effect Effects 0.000 description 6
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 5
- 230000001603 reducing effect Effects 0.000 description 5
- 239000012488 sample solution Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 206010059866 Drug resistance Diseases 0.000 description 4
- 235000006679 Mentha X verticillata Nutrition 0.000 description 4
- 235000002899 Mentha suaveolens Nutrition 0.000 description 4
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 4
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 4
- 208000016150 acute pharyngitis Diseases 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 238000001704 evaporation Methods 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 3
- 244000236658 Paeonia lactiflora Species 0.000 description 3
- 235000008598 Paeonia lactiflora Nutrition 0.000 description 3
- 235000001368 chlorogenic acid Nutrition 0.000 description 3
- 229940074393 chlorogenic acid Drugs 0.000 description 3
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 3
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 3
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 3
- 230000000916 dilatatory effect Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- -1 hydroxy paeoniflorin Chemical compound 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000002633 protecting effect Effects 0.000 description 3
- 230000002040 relaxant effect Effects 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 238000009210 therapy by ultrasound Methods 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- XHXUANMFYXWVNG-ADEWGFFLSA-N (-)-Menthyl acetate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O XHXUANMFYXWVNG-ADEWGFFLSA-N 0.000 description 2
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
- RGHHSNMVTDWUBI-UHFFFAOYSA-N 4-hydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1 RGHHSNMVTDWUBI-UHFFFAOYSA-N 0.000 description 2
- 206010002660 Anoxia Diseases 0.000 description 2
- 241000976983 Anoxia Species 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 206010021143 Hypoxia Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- 244000167230 Lonicera japonica Species 0.000 description 2
- 235000017617 Lonicera japonica Nutrition 0.000 description 2
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 2
- 241000736199 Paeonia Species 0.000 description 2
- RMMPZDDLWLALLJ-UHFFFAOYSA-N Thermophillin Chemical compound COC1=CC(=O)C(OC)=CC1=O RMMPZDDLWLALLJ-UHFFFAOYSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000007953 anoxia Effects 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 230000003276 anti-hypertensive effect Effects 0.000 description 2
- 230000001754 anti-pyretic effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 239000002221 antipyretic Substances 0.000 description 2
- 229960001230 asparagine Drugs 0.000 description 2
- 235000009582 asparagine Nutrition 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- ROAYSRAUMPWBQX-UHFFFAOYSA-N ethanol;sulfuric acid Chemical compound CCO.OS(O)(=O)=O ROAYSRAUMPWBQX-UHFFFAOYSA-N 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 2
- 235000012141 vanillin Nutrition 0.000 description 2
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 2
- 229940126673 western medicines Drugs 0.000 description 2
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- NFLGAXVYCFJBMK-IUCAKERBSA-N (-)-isomenthone Chemical compound CC(C)[C@@H]1CC[C@H](C)CC1=O NFLGAXVYCFJBMK-IUCAKERBSA-N 0.000 description 1
- CWVRJTMFETXNAD-BMNNCGMMSA-N (1s,3r,4s,5r)-3-[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylic acid Chemical compound O[C@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-BMNNCGMMSA-N 0.000 description 1
- 239000001605 (5-methyl-2-propan-2-ylcyclohexyl) acetate Substances 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- BGNGWHSBYQYVRX-UHFFFAOYSA-N 4-(dimethylamino)benzaldehyde Chemical compound CN(C)C1=CC=C(C=O)C=C1 BGNGWHSBYQYVRX-UHFFFAOYSA-N 0.000 description 1
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 1
- LATYEZNGPQKAIK-UHFFFAOYSA-N 6'-O-benzoylpaeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(COC(=O)C=6C=CC=CC=6)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 LATYEZNGPQKAIK-UHFFFAOYSA-N 0.000 description 1
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- LATYEZNGPQKAIK-HRCYFWENSA-N Benzoylpaeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](COC(=O)C=2C=CC=CC=2)O1)O)C)OC(=O)C1=CC=CC=C1 LATYEZNGPQKAIK-HRCYFWENSA-N 0.000 description 1
- 201000004813 Bronchopneumonia Diseases 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- 235000018959 Chrysanthemum indicum Nutrition 0.000 description 1
- 240000005250 Chrysanthemum indicum Species 0.000 description 1
- XHXUANMFYXWVNG-UHFFFAOYSA-N D-menthyl acetate Natural products CC(C)C1CCC(C)CC1OC(C)=O XHXUANMFYXWVNG-UHFFFAOYSA-N 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- KVRQGMOSZKPBNS-FMHLWDFHSA-N Harpagoside Chemical compound O([C@@H]1OC=C[C@@]2(O)[C@H](O)C[C@]([C@@H]12)(C)OC(=O)\C=C\C=1C=CC=CC=1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O KVRQGMOSZKPBNS-FMHLWDFHSA-N 0.000 description 1
- KVRQGMOSZKPBNS-BYYMOQGZSA-N Harpagoside Natural products C[C@@]1(C[C@@H](O)[C@@]2(O)C=CO[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H]12)OC(=O)C=Cc4ccccc4 KVRQGMOSZKPBNS-BYYMOQGZSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241000589902 Leptospira Species 0.000 description 1
- 241000245240 Lonicera Species 0.000 description 1
- 241000100289 Lonicera confusa Species 0.000 description 1
- 241000173699 Lonicera dasystyla Species 0.000 description 1
- 241001170080 Lonicera hypoglauca Species 0.000 description 1
- 241000498975 Lonicera maackii Species 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 235000001878 Mentha haplocalyx Nutrition 0.000 description 1
- 244000280293 Mentha haplocalyx Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- IBPFZCOJYVDKGN-UHFFFAOYSA-N OC.OC=O.ClC(Cl)Cl.CCOC(C)=O Chemical compound OC.OC=O.ClC(Cl)Cl.CCOC(C)=O IBPFZCOJYVDKGN-UHFFFAOYSA-N 0.000 description 1
- 241000123968 Paeonia anomala Species 0.000 description 1
- 241000124464 Paeonia veitchii Species 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241001492451 Pterodon Species 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 description 1
- 241001121987 Scrophularia ningpoensis Species 0.000 description 1
- 241000207844 Scrophulariaceae Species 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 235000005811 Viola adunca Nutrition 0.000 description 1
- 240000009038 Viola odorata Species 0.000 description 1
- 235000013487 Viola odorata Nutrition 0.000 description 1
- 235000002254 Viola papilionacea Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- VIWQCBZFJFSCLC-UHFFFAOYSA-N alpha-benzoyloxypaeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(COC(=O)C=6C=CC=CC=6)O5)O)CC3(O)OC1C24COC(=O)C1=CC=C(O)C=C1 VIWQCBZFJFSCLC-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003509 anti-fertility effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 230000002790 anti-mutagenic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- JXQGGZBUGUHLEJ-UHFFFAOYSA-N butyl acetate formic acid hydrate Chemical compound O.OC=O.CCCCOC(C)=O JXQGGZBUGUHLEJ-UHFFFAOYSA-N 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 229930006739 camphene Natural products 0.000 description 1
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- SIHHLZPXQLFPMC-UHFFFAOYSA-N chloroform;methanol;hydrate Chemical compound O.OC.ClC(Cl)Cl SIHHLZPXQLFPMC-UHFFFAOYSA-N 0.000 description 1
- 239000008845 cholagoga Substances 0.000 description 1
- 229940124571 cholagogue Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- DKZBBWMURDFHNE-NSCUHMNNSA-N coniferyl aldehyde Chemical compound COC1=CC(\C=C\C=O)=CC=C1O DKZBBWMURDFHNE-NSCUHMNNSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- OAMZXMDZZWGPMH-UHFFFAOYSA-N ethyl acetate;toluene Chemical compound CCOC(C)=O.CC1=CC=CC=C1 OAMZXMDZZWGPMH-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229960005219 gentisic acid Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 244000000053 intestinal parasite Species 0.000 description 1
- KRZBCHWVBQOTNZ-DLDRDHNVSA-N isochlorogenic acid Natural products O[C@@H]1[C@H](C[C@@](O)(C[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)C(=O)O)OC(=O)C=Cc3ccc(O)c(O)c3 KRZBCHWVBQOTNZ-DLDRDHNVSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 229920005610 lignin Polymers 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 238000004634 pharmacological analysis method Methods 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- YQUVCSBJEUQKSH-UHFFFAOYSA-N protochatechuic acid Natural products OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 description 1
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000004799 sedative–hypnotic effect Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 210000003699 striated muscle Anatomy 0.000 description 1
- KCDXJAYRVLXPFO-UHFFFAOYSA-N syringaldehyde Chemical compound COC1=CC(C=O)=CC(OC)=C1O KCDXJAYRVLXPFO-UHFFFAOYSA-N 0.000 description 1
- COBXDAOIDYGHGK-UHFFFAOYSA-N syringaldehyde Natural products COC1=CC=C(C=O)C(OC)=C1O COBXDAOIDYGHGK-UHFFFAOYSA-N 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- DKZBBWMURDFHNE-UHFFFAOYSA-N trans-coniferylaldehyde Natural products COC1=CC(C=CC=O)=CC=C1O DKZBBWMURDFHNE-UHFFFAOYSA-N 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- WKOLLVMJNQIZCI-UHFFFAOYSA-N vanillic acid Chemical compound COC1=CC(C(O)=O)=CC=C1O WKOLLVMJNQIZCI-UHFFFAOYSA-N 0.000 description 1
- TUUBOHWZSQXCSW-UHFFFAOYSA-N vanillic acid Natural products COC1=CC(O)=CC(C(O)=O)=C1 TUUBOHWZSQXCSW-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses Yi medicine Jin Lingqing pharyngeal granules and a preparation method thereof, wherein the Yi medicine Jin Lingqing pharyngeal granules comprise the following raw materials in parts by weight: 1.67-25.05 parts of honeysuckle (Yi nationality: also resistant to Yi nationality), 1.11-16.65 parts of pterodontoseisis (Yi nationality: bei Naipa), 1.11-16.65 parts of peppermint (Yi nationality: pacifica) 1.38-26.27 parts of reed rhizome (Yi nationality: suan ruan), 13.72-34.92 parts of red paeony root (Yi nationality: yi QI Po ZU) and 13.72-34.92 parts of figwort. The invention is derived from Yi nationality ancient Fang Jiajian chemical formula, belongs to a medicine for clearing heat, relieving sore throat and resolving phlegm, has the effects of detoxification and relieving sore throat, and has good effect on pharyngitis. The invention is a pure Chinese (Yi-nationality) medicine preparation, can cooperate with antimicrobial, anti-inflammatory and antioxidant effects, effectively improves the decomposition rate of the medicine in vivo, and is easy to absorb; the invention is a Yi nationality medicine conversion product in Sichuan province, has definite curative effect, safety and reliability and is suitable for popularization and application.
Description
Technical Field
The invention belongs to the technical field of medicine preparation, and particularly relates to Yi medicine Jin Lingqing pharyngeal granules and a preparation method thereof.
Background
Pharyngitis is very common, has huge medical and social costs, and reportedly shows that: 1) The proportion of patients with chronic pharyngitis in the patients with the clinic of the otorhinolaryngology department in daily visit is close to 1/3; 2) Statistical analysis is performed on 1100 healthy physical examination persons, and the incidence rate of chronic pharyngitis in the result population is as high as 78.65%.
Western medicine antibiotics and the like can easily cause bacteria in human bodies to lose cell walls to form bacteria L-shape, generate drug resistance, and cause repeated attacks and lasting disunion of chronic pharyngitis; and the western medicines are easy to produce allergic reaction and adverse reaction.
Clinical researches show that the medicament for treating the chronic pharyngitis on the market at present has low total effective rate for treating the chronic pharyngitis.
The combined treatment scheme of the traditional Chinese medicine and the western medicine can effectively improve the total effective rate, reduce the pharyngalgia score and reduce the dosage and the treatment course of antibiotics and hormone compared with the single treatment scheme of the western medicine.
The traditional Chinese medicine composition is derived from ancient and proved prescriptions of Yi nationality, and has definite curative effect on pharyngitis based on the basic rules of treatment of the basis and the theory of the upper law of Yi nationality. Therefore, it is necessary to develop a national medicine Chinese medicine (Yi medicine) preparation with high total effective rate specially aiming at acute and chronic pharyngitis.
Disclosure of Invention
In order to solve the problems, the technical scheme of the invention is as follows:
a Yi medicine Jin Lingqing pharyngeal particle, which comprises the following raw materials in parts by weight: 1.67-25.05 parts of honeysuckle (Yi nationality: also resistant to Yi nationality), 1.11-16.65 parts of pterodontoseisis (Yi nationality: bei Naipa), 1.11-16.65 parts of peppermint (Yi nationality: pacifica) 1.38-26.27 parts of reed rhizome (Yi nationality: suan ruyi), 13.72-34.92 parts of red peony (Yi nationality: yi QI Po ZU) and 13.72-34.92 parts of radix scrophulariae.
The invention has the function of treating acute and chronic pharyngitis and has the basis of traditional Chinese medicine pathology and modern pharmacological analysis.
The main components and pharmacological actions of Jin Lingqing pharyngeal granules are as follows:
honeysuckle flower:
latin name: flos Lonicerae
Description of medicinal materials: dried flower buds or first-placed flowers of Lonicera japonica (Lonicera japonica thunder.) of Caprifoliaceae, lonicera praecox (Lonicera hypoglauca Miq.), lonicera confusa DC, and Lonicera maackii (Lonicera dasystyla Red.) are harvested in 1990 edition of pharmacopoeia of the people's republic of China.
Medicinal material nature taste: sweet in flavor and cold in nature.
Pharmacological action: antipyretic, cooling, exciting, reducing blood lipid, resisting fertility, regulating immunity, relieving inflammation, resisting bacteria, viruses, fungi, leptospira, resisting tumor, sensitization, and removing toxic substances
Description of the functions: can clear away heat and toxic materials, cool and dissipate wind-heat.
Functional action: clear away heat and toxic materials.
The medicinal materials enter the meridian: enter lung, heart and stomach meridians.
The main components are as follows: comprises chlorogenic acid, isochlorogenic acid, luteolin, inositol, volatile oil, etc.
Pterodon japonicus:
latin name: herba Laggerae
Description of medicinal materials: dried aerial parts of the Compositae plant, dendranthema indicum Laggera pterodonta (Candolle) Bentham.
Medicinal material nature taste: cool in nature, pungent and bitter in flavor.
Pharmacological action: antibacterial, antiinflammatory, phlegm eliminating, cough relieving, antitumor, malaria treating, antiviral, etc.
Description of the functions: has effects in clearing away heat and toxic materials, relieving cough, and eliminating phlegm.
Functional action: clear away heat and toxic materials.
The medicinal materials enter the meridian: enter lung meridian and stomach meridian.
The main components are as follows: contains flavonoids, terpenes, organic acids, lactones, phenols, reducing sugar, polysaccharide, and oil.
Peppermint:
latin name: herba Menthae
Description of medicinal materials: the dry aerial parts of the Labiatae plant peppermint (Mentha haplocalyx Briq.) are collected in the 1990 edition of the pharmacopoeia of the people's republic of China.
Medicinal material nature taste: pungent in flavor and cool in nature.
Pharmacological action: analgesic, striated muscle relaxing, antihypertensive, peripheral vascular dilating, antitussive, smooth muscle inhibiting, healing, cholagogue, liver protecting, phlegm eliminating, antifertility, antiinflammatory, antiallergic, antihistamine, antibacterial, antiviral, antifungal, intestinal parasite resisting, skin mucosa treating, and insecticidal effects.
Description of the functions: has effects of dispelling pathogenic wind heat, clearing head and eyes, and promoting eruption.
Functional action: dispersing wind-heat, promoting qi circulation, soothing liver, relieving sore throat, promoting eruption, and clearing head and eyes.
The medicinal materials enter the meridian: it enters lung and liver meridians.
The main components are as follows: the essential oil contains menthol and menthone, menthyl acetate, limonene, camphene, isomenthone, pinene, menthenone, resin, small amount of tannins, rosmarinic acid, etc.
Reed rhizome:
latin name: rhizoma Phragmitis
Description of medicinal materials: is rhizome of reed belonging to Gramineae.
Medicinal material nature taste: sweet in flavor and cold in nature.
Pharmacological action: has effects in inhibiting skeletal muscle, relaxing intestinal canal, and enhancing immunity.
Functional action: stopping hiccup, clearing heat, promoting fluid production to quench thirst, promoting diuresis, relieving restlessness and promoting eruption.
The medicinal materials enter the meridian: lung, stomach, bladder meridian.
The main components are as follows: contains abundant vitamins B1, B2, C and proteins 5%, fat 1%, carbohydrate 51%, and asparagine 0.1%. And contains amino acids, fatty acids, sterols, tocopherols, polyphenols such as caffeic acid and gentisic acid. Also contains 2, 5-dimethoxy-p-benzoquinone, p-hydroxybenzaldehyde, syringaldehyde, coniferyl aldehyde, vanillic acid, ferulic acid, p-coumaric acid, dioxane lignin, etc.
Radix paeoniae rubra:
latin name: paeonia anomala L.
Description of medicinal materials: dried root of Paeonia lactiflora (Paeonia lactiflora pall.) and Paeonia lactiflora (Paeonia veitchii Lynch) belonging to Ranunculaceae is collected in 1990 edition of pharmacopoeia of the people's republic of China.
Medicinal material nature taste: bitter and slightly cold.
Pharmacological action: sedative hypnotic, analgesic, coronary vessel dilating, blood pressure lowering, anoxia tolerance improving, blood lipid reducing, atherosclerosis resisting, anticoagulant, antithrombotic, platelet aggregation resisting, digestive juice secretion promoting, liver protecting, antioxidant, lung function improving, antibacterial, antitumor, and antimutagenic effects.
Description of the functions: has the functions of clearing heat, cooling blood and removing blood stasis.
Functional action: promoting blood circulation, removing blood stasis, clearing heat and cooling blood.
The medicinal materials enter the meridian: enter liver meridian.
The main components are as follows: contains paeoniflorin, and further contains paeoniflorin, hydroxy paeoniflorin, and benzoyl paeoniflorin; and benzoic acid and tannins are contained. Paeonia root is reported to contain (Z) - (1S, 5R) -beta-pinen-10 yl beta-hiberoside, paeoniflorin, and the like.
Radix scrophulariae:
latin name: radix Scrophulariae
Description of medicinal materials: the dried root of radix scrophulariae (Scrophularia ningpoensis hemsl.) belonging to Scrophulariaceae is harvested in 1990 edition of pharmacopoeia of the people's republic of China.
Medicinal material nature taste: slightly cold in nature, sweet in taste, bitter and salty.
Pharmacological action: antipyretic, cooling, antihypertensive, coronary vessel dilating, myocardial ischemia resisting, anoxia resisting, blood sugar reducing, antibacterial and antifungal effects.
Description of the functions: has effects of cooling blood, nourishing yin, purging pathogenic fire, and removing toxic substances.
Functional action: resolving hard mass, nourishing yin, lowering fire, clearing heat, cooling blood and detoxicating.
The medicinal materials enter the meridian: it enters lung, stomach and kidney meridians.
The main components are as follows: contains iridoids such as Ha Badai, 8- (o-methyl-p-coumaroyl) -harpagin, asparagine and trace volatile oil, phytosterol, alkaloid, saccharide, fatty acid and carotene.
In conclusion, the honeysuckle, the laggera pterodonta, the peppermint, the reed rhizome, the red paeony root and the figwort can synergistically play the comprehensive functions of regulating immunity, resisting viruses and bacteria, protecting lung and liver, resisting inflammation, resisting oxidation, improving microcirculation, relieving cough and reducing sputum, treat both principal and secondary aspect of disease and can be used for treating acute and chronic pharyngitis.
A preparation method of Yi medicine Jin Lingqing pharyngeal granules comprises the following steps:
firstly, taking honeysuckle, laggera pterodonta, peppermint, reed rhizome, red paeony root and figwort root according to the mass parts, putting the honeysuckle, the laggera pterodonta, the peppermint, the reed rhizome, the red paeony root and the figwort root into a 1 ton extraction tank, adding 10 times of drinking water for the first time, soaking for 30 minutes, starting a reflux device to collect reflux liquid, keeping the liquid level slightly boiling after boiling, starting timing with the reflux of a first drop of reflux liquid, distilling medicinal materials for 30 minutes, and putting the reflux liquid into a closed container for standby. And (5) closing the reflux device for continuous decoction for 30 minutes, and filtering the liquid medicine by a 80-mesh screen for later use.
Adding 10 times of drinking water respectively for the second time and the third time, decocting for 60 minutes each time, filtering the decoction by a 80-mesh screen after the decoction is finished, and combining the three filtrates to be concentrated.
And thirdly, mixing the extracting solution extracted for three times and the reflux liquid, then sucking the mixture into a single-effect concentrator, controlling the vacuum degree to be- (0.075-0.085 Mpa), concentrating the mixture at the concentration temperature of 45-55 ℃ under reduced pressure, and concentrating the mixture into extractum with the relative density of 1.36-1.39 (50 ℃) for later use.
Step four, granulating: the sucrose is crushed by 80 meshes to obtain sucrose powder, 1 part of extract with qualified relative density, 1 part of dextrin and 4 parts of sucrose powder are weighed, the sucrose powder and the dextrin are poured into a groove type mixer and stirred for 3 minutes, the extract and purified water or 75% ethanol are added to prepare a proper soft material, and the soft material is granulated by a 14-mesh nylon net swing granulator.
And fifthly, putting the prepared wet particles into a fluidized bed dryer, setting the drying temperature to be 60 ℃ for drying, and taking out of the pot after the moisture of the particles is lower than 2.0%.
Step six, the dried granules are finished by a stainless steel screen mesh with 10 meshes and 28 meshes, qualified granules are obtained in the middle of 10 meshes to 28 meshes, and the qualified granules are put into a turnover barrel for standby.
And seventhly, subpackaging the qualified particles by using a blank coiled film with the specification of 140mm, wherein the packaging amount is controlled between 9.7 and 10.4g during subpackaging.
Due to the adoption of the technical scheme, the beneficial effects obtained by the invention are as follows:
the invention belongs to a medicine for clearing heat, relieving sore throat and resolving phlegm, has the effects of ascending the clear and descending the turbid, removing toxin and relieving sore throat, removing blood stasis and dredging collaterals and relieving pain, cooling blood and nourishing yin, and has good effects on pharyngitis excess syndrome and deficiency-excess syndrome. The invention is a pure traditional Chinese medicine preparation, can cooperate with antimicrobial, anti-inflammatory and antioxidant effects, improves local symptoms, reduces drug resistance caused by abuse of antibiotics, and has higher safety; the invention can effectively improve the decomposition rate of the medicine in vivo, is easy to absorb and has high bioavailability; the invention has definite curative effect, safety, reliability and convenient administration, and is worthy of popularization and application. The product belongs to one of the first Yi medicine research and development conversion products of Sichuan province.
Detailed Description
The invention is further illustrated by the following examples. The following examples are illustrative of the invention and are not intended to limit the scope of the invention. The technical means used in the examples are conventional means well known to those skilled in the art unless otherwise indicated.
Example 1
1. Raw material proportioning
2. Product preparation
Firstly, taking honeysuckle, laggera pterodonta, peppermint, reed rhizome, red paeony root and figwort root according to the mass parts, putting the honeysuckle, the laggera pterodonta, the peppermint, the reed rhizome, the red paeony root and the figwort root into a 1 ton extraction tank, adding 10 times of drinking water for the first time, soaking for 30 minutes, starting a reflux device to collect reflux liquid, keeping the liquid level slightly boiling after boiling, starting timing with the reflux of a first drop of reflux liquid, distilling medicinal materials for 30 minutes, and putting the reflux liquid into a closed container for standby. And (5) closing the reflux device for continuous decoction for 30 minutes, and filtering the liquid medicine by a 80-mesh screen for later use.
Adding 10 times of drinking water respectively for the second time and the third time, decocting for 60 minutes each time, filtering the decoction by a 80-mesh screen after the decoction is finished, and combining the three filtrates to be concentrated.
And thirdly, mixing the extracting solution extracted for three times and the reflux liquid, then sucking the mixture into a single-effect concentrator, controlling the vacuum degree to be- (0.075-0.085 Mpa), concentrating the mixture at the concentration temperature of 45-55 ℃ under reduced pressure, and concentrating the mixture into extractum with the relative density of 1.36-1.39 (50 ℃) for later use.
Step four, granulating: the sucrose is crushed by 80 meshes to obtain sucrose powder, 1 part of extract with qualified relative density, 1 part of dextrin and 4 parts of sucrose powder are weighed, the sucrose powder and the dextrin are poured into a groove type mixer and stirred for 3 minutes, the extract and purified water or 75% ethanol are added to prepare a proper soft material, and the soft material is granulated by a 14-mesh nylon net swing granulator.
And fifthly, putting the prepared wet particles into a fluidized bed dryer, setting the drying temperature to be 60 ℃ for drying, and taking out of the pot after the moisture of the particles is lower than 2.0%.
Step six, the dried granules are finished by a stainless steel screen mesh with 10 meshes and 28 meshes, qualified granules are obtained in the middle of 10 meshes to 28 meshes, and the qualified granules are put into a turnover barrel for standby.
And seventhly, subpackaging the qualified particles by using a blank coiled film with the specification of 140mm, wherein the packaging amount is controlled between 9.7 and 10.4g during subpackaging.
Example 2
1. Raw material proportioning
2. Product preparation
Firstly, taking honeysuckle, laggera pterodonta, peppermint, reed rhizome, red paeony root and figwort root according to the mass parts, putting the honeysuckle, the laggera pterodonta, the peppermint, the reed rhizome, the red paeony root and the figwort root into a 1 ton extraction tank, adding 10 times of drinking water for the first time, soaking for 30 minutes, starting a reflux device to collect reflux liquid, keeping the liquid level slightly boiling after boiling, starting timing with the reflux of a first drop of reflux liquid, distilling medicinal materials for 30 minutes, and putting the reflux liquid into a closed container for standby. And (5) closing the reflux device for continuous decoction for 30 minutes, and filtering the liquid medicine by a 80-mesh screen for later use.
Adding 10 times of drinking water respectively for the second time and the third time, decocting for 60 minutes each time, filtering the decoction by a 80-mesh screen after the decoction is finished, and combining the three filtrates to be concentrated.
And thirdly, mixing the extracting solution extracted for three times and the reflux liquid, then sucking the mixture into a single-effect concentrator, controlling the vacuum degree to be- (0.075-0.085 Mpa), concentrating the mixture at the concentration temperature of 45-55 ℃ under reduced pressure, and concentrating the mixture into extractum with the relative density of 1.36-1.39 (50 ℃) for later use.
Step four, granulating: the sucrose is crushed by 80 meshes to obtain sucrose powder, 1 part of extract with qualified relative density, 1 part of dextrin and 4 parts of sucrose powder are weighed, the sucrose powder and the dextrin are poured into a groove type mixer and stirred for 3 minutes, the extract and purified water or 75% ethanol are added to prepare a proper soft material, and the soft material is granulated by a 14-mesh nylon net swing granulator.
And fifthly, putting the prepared wet particles into a fluidized bed dryer, setting the drying temperature to be 60 ℃ for drying, and taking out of the pot after the moisture of the particles is lower than 2.0%.
Step six, the dried granules are finished by a stainless steel screen mesh with 10 meshes and 28 meshes, qualified granules are obtained in the middle of 10 meshes to 28 meshes, and the qualified granules are put into a turnover barrel for standby.
And seventhly, subpackaging the qualified particles by using a blank coiled film with the specification of 140mm, wherein the packaging amount is controlled between 9.7 and 10.4g during subpackaging.
Example 3
1. Raw material proportioning
| Raw materials | Formula amount (proportion%) |
| Honeysuckle | 8.35 |
| Herba Clerodendranthi Spicati | 5.55 |
| Mint | 5.55 |
| Rhizoma Phragmitis | 22.02 |
| Radix paeoniae rubra | 29.27 |
| Radix scrophulariae | 29.27 |
2. Product preparation
Firstly, taking honeysuckle, laggera pterodonta, peppermint, reed rhizome, red paeony root and figwort root according to the mass parts, putting the honeysuckle, the laggera pterodonta, the peppermint, the reed rhizome, the red paeony root and the figwort root into a 1 ton extraction tank, adding 10 times of drinking water for the first time, soaking for 30 minutes, starting a reflux device to collect reflux liquid, keeping the liquid level slightly boiling after boiling, starting timing with the reflux of a first drop of reflux liquid, distilling medicinal materials for 30 minutes, and putting the reflux liquid into a closed container for standby. And (5) closing the reflux device for continuous decoction for 30 minutes, and filtering the liquid medicine by a 80-mesh screen for later use.
Adding 10 times of drinking water respectively for the second time and the third time, decocting for 60 minutes each time, filtering the decoction by a 80-mesh screen after the decoction is finished, and combining the three filtrates to be concentrated.
And thirdly, mixing the extracting solution extracted for three times and the reflux liquid, then sucking the mixture into a single-effect concentrator, controlling the vacuum degree to be- (0.075-0.085 Mpa), concentrating the mixture at the concentration temperature of 45-55 ℃ under reduced pressure, and concentrating the mixture into extractum with the relative density of 1.36-1.39 (50 ℃) for later use.
Step four, granulating: the sucrose is crushed by 80 meshes to obtain sucrose powder, 1 part of extract with qualified relative density, 1 part of dextrin and 4 parts of sucrose powder are weighed, the sucrose powder and the dextrin are poured into a groove type mixer and stirred for 3 minutes, the extract and purified water or 75% ethanol are added to prepare a proper soft material, and the soft material is granulated by a 14-mesh nylon net swing granulator.
And fifthly, putting the prepared wet particles into a fluidized bed dryer, setting the drying temperature to be 60 ℃ for drying, and taking out of the pot after the moisture of the particles is lower than 2.0%.
Step six, the dried granules are finished by a stainless steel screen mesh with 10 meshes and 28 meshes, qualified granules are obtained in the middle of 10 meshes to 28 meshes, and the qualified granules are put into a turnover barrel for standby.
And seventhly, subpackaging the qualified particles by using a blank coiled film with the specification of 140mm, wherein the packaging amount is controlled between 9.7 and 10.4g during subpackaging.
Example 4
1. Raw material proportioning
| Raw materials | Formula amount (proportion%) |
| Honeysuckle | 26.72 |
| Herba Clerodendranthi Spicati | 17.76 |
| Mint | 17.76 |
| Rhizoma Phragmitis | 10.32 |
| Radix paeoniae rubra | 13.72 |
| Radix scrophulariae | 13.72 |
2. Product preparation
Firstly, taking honeysuckle, laggera pterodonta, peppermint, reed rhizome, red paeony root and figwort root according to the mass parts, putting the honeysuckle, the laggera pterodonta, the peppermint, the reed rhizome, the red paeony root and the figwort root into a 1 ton extraction tank, adding 10 times of drinking water for the first time, soaking for 30 minutes, starting a reflux device to collect reflux liquid, keeping the liquid level slightly boiling after boiling, starting timing with the reflux of a first drop of reflux liquid, distilling medicinal materials for 30 minutes, and putting the reflux liquid into a closed container for standby. And (5) closing the reflux device for continuous decoction for 30 minutes, and filtering the liquid medicine by a 80-mesh screen for later use.
Adding 10 times of drinking water respectively for the second time and the third time, decocting for 60 minutes each time, filtering the decoction by a 80-mesh screen after the decoction is finished, and combining the three filtrates to be concentrated.
And thirdly, mixing the extracting solution extracted for three times and the reflux liquid, then sucking the mixture into a single-effect concentrator, controlling the vacuum degree to be- (0.075-0.085 Mpa), concentrating the mixture at the concentration temperature of 45-55 ℃ under reduced pressure, and concentrating the mixture into extractum with the relative density of 1.36-1.39 (50 ℃) for later use.
Step four, granulating: the sucrose is crushed by 80 meshes to obtain sucrose powder, 1 part of extract with qualified relative density, 1 part of dextrin and 4 parts of sucrose powder are weighed, the sucrose powder and the dextrin are poured into a groove type mixer and stirred for 3 minutes, the extract and purified water or 75% ethanol are added to prepare a proper soft material, and the soft material is granulated by a 14-mesh nylon net swing granulator.
And fifthly, putting the prepared wet particles into a fluidized bed dryer, setting the drying temperature to be 60 ℃ for drying, and taking out of the pot after the moisture of the particles is lower than 2.0%.
Step six, the dried granules are finished by a stainless steel screen mesh with 10 meshes and 28 meshes, qualified granules are obtained in the middle of 10 meshes to 28 meshes, and the qualified granules are put into a turnover barrel for standby.
And seventhly, subpackaging the qualified particles by using a blank coiled film with the specification of 140mm, wherein the packaging amount is controlled between 9.7 and 10.4g during subpackaging.
Example 5
1. Raw material proportioning
| Raw materials | Formula amount (proportion%) |
| Honeysuckle | 3.34 |
| Herba Clerodendranthi Spicati | 2.22 |
| Mint | 2.22 |
| Rhizoma Phragmitis | 25.21 |
| Radix paeoniae rubra | 33.51 |
| Radix scrophulariae | 33.51 |
2. Product preparation
Firstly, taking honeysuckle, laggera pterodonta, peppermint, reed rhizome, red paeony root and figwort root according to the mass parts, putting the honeysuckle, the laggera pterodonta, the peppermint, the reed rhizome, the red paeony root and the figwort root into a 1 ton extraction tank, adding 10 times of drinking water for the first time, soaking for 30 minutes, starting a reflux device to collect reflux liquid, keeping the liquid level slightly boiling after boiling, starting timing with the reflux of a first drop of reflux liquid, distilling medicinal materials for 30 minutes, and putting the reflux liquid into a closed container for standby. And (5) closing the reflux device for continuous decoction for 30 minutes, and filtering the liquid medicine by a 80-mesh screen for later use.
Adding 10 times of drinking water respectively for the second time and the third time, decocting for 60 minutes each time, filtering the decoction by a 80-mesh screen after the decoction is finished, and combining the three filtrates to be concentrated.
And thirdly, mixing the extracting solution extracted for three times and the reflux liquid, then sucking the mixture into a single-effect concentrator, controlling the vacuum degree to be- (0.075-0.085 Mpa), concentrating the mixture at the concentration temperature of 45-55 ℃ under reduced pressure, and concentrating the mixture into extractum with the relative density of 1.36-1.39 (50 ℃) for later use.
Step four, granulating: the sucrose is crushed by 80 meshes to obtain sucrose powder, 1 part of extract with qualified relative density, 1 part of dextrin and 4 parts of sucrose powder are weighed, the sucrose powder and the dextrin are poured into a groove type mixer and stirred for 3 minutes, the extract and purified water or 75% ethanol are added to prepare a proper soft material, and the soft material is granulated by a 14-mesh nylon net swing granulator.
And fifthly, putting the prepared wet particles into a fluidized bed dryer, setting the drying temperature to be 60 ℃ for drying, and taking out of the pot after the moisture of the particles is lower than 2.0%.
Step six, the dried granules are finished by a stainless steel screen mesh with 10 meshes and 28 meshes, qualified granules are obtained in the middle of 10 meshes to 28 meshes, and the qualified granules are put into a turnover barrel for standby.
And seventhly, subpackaging the qualified particles by using a blank coiled film with the specification of 140mm, wherein the packaging amount is controlled between 9.7 and 10.4g during subpackaging.
Example 6
1. Raw material proportioning
| Raw materials | Formula amount (proportion%) |
| Honeysuckle | 1.67 |
| Herba Clerodendranthi Spicati | 1.11 |
| Mint | 1.11 |
| Rhizoma Phragmitis | 26.27 |
| Radix paeoniae rubra | 34.92 |
| Radix scrophulariae | 34.92 |
2. Product preparation
Firstly, taking honeysuckle, laggera pterodonta, peppermint, reed rhizome, red paeony root and figwort root according to the mass parts, putting the honeysuckle, the laggera pterodonta, the peppermint, the reed rhizome, the red paeony root and the figwort root into a 1 ton extraction tank, adding 10 times of drinking water for the first time, soaking for 30 minutes, starting a reflux device to collect reflux liquid, keeping the liquid level slightly boiling after boiling, starting timing with the reflux of a first drop of reflux liquid, distilling medicinal materials for 30 minutes, and putting the reflux liquid into a closed container for standby. And (5) closing the reflux device for continuous decoction for 30 minutes, and filtering the liquid medicine by a 80-mesh screen for later use.
Adding 10 times of drinking water respectively for the second time and the third time, decocting for 60 minutes each time, filtering the decoction by a 80-mesh screen after the decoction is finished, and combining the three filtrates to be concentrated.
And thirdly, mixing the extracting solution extracted for three times and the reflux liquid, then sucking the mixture into a single-effect concentrator, controlling the vacuum degree to be- (0.075-0.085 Mpa), concentrating the mixture at the concentration temperature of 45-55 ℃ under reduced pressure, and concentrating the mixture into extractum with the relative density of 1.36-1.39 (50 ℃) for later use.
Step four, granulating: the sucrose is crushed by 80 meshes to obtain sucrose powder, 1 part of extract with qualified relative density, 1 part of dextrin and 4 parts of sucrose powder are weighed, the sucrose powder and the dextrin are poured into a groove type mixer and stirred for 3 minutes, the extract and purified water or 75% ethanol are added to prepare a proper soft material, and the soft material is granulated by a 14-mesh nylon net swing granulator.
And fifthly, putting the prepared wet particles into a fluidized bed dryer, setting the drying temperature to be 60 ℃ for drying, and taking out of the pot after the moisture of the particles is lower than 2.0%.
Step six, the dried granules are finished by a stainless steel screen mesh with 10 meshes and 28 meshes, qualified granules are obtained in the middle of 10 meshes to 28 meshes, and the qualified granules are put into a turnover barrel for standby.
And seventhly, subpackaging the qualified particles by using a blank coiled film with the specification of 140mm, wherein the packaging amount is controlled between 9.7 and 10.4g during subpackaging.
[ Property ]
The product is brown yellow granule, has fragrant smell, and sweet and slightly bitter taste.
[ identification ]
(1) Taking 0.2g of the product powder, adding 5ml of methanol, standing for 12 hours, filtering, and taking filtrate as a sample solution. And adding methanol into chlorogenic acid reference substance to obtain 1mg solution per 1ml, and taking the chlorogenic acid reference substance solution as reference substance solution. According to a thin layer chromatography (general rule 0502) test, sucking 10-20 mu l of sample solution and 10 mu l of reference substance solution, respectively spotting on the same silica gel H thin layer plate, taking an upper layer solution of butyl acetate-formic acid-water (7:2.5:2.5) as a developing agent, developing, taking out, airing, and putting under an ultraviolet lamp (365 nm) for detection. In the chromatogram of the test sample, fluorescent spots with the same color appear at the positions corresponding to the chromatogram of the reference sample.
(2) Taking 3g of the product powder, adding 50ml of methanol, heating and refluxing for 30 minutes, filtering, evaporating filtrate to dryness, and adding 2ml of methanol into residues to dissolve the residues to obtain a sample solution. And adding methanol into the oceanic mugwort reference substance to prepare a solution with 1mg per 1ml as a reference substance solution. According to thin layer chromatography (general rule 0502), 5 μl of each of the above two solutions was sucked and spotted on the same silica gel GF254 thin layer plate, and developed with dichloromethane-ethyl formate-acetone (6:0.5:0.3) as developing agent, taken out, dried, and inspected under ultraviolet lamp (254 nm). Spots of the same color appear in the sample chromatogram at positions corresponding to those of the control chromatogram.
(3) Taking 1g of coarse powder of the product, adding 10ml of absolute ethyl alcohol, carrying out ultrasonic treatment for 20 minutes, filtering, and taking filtrate as a sample solution. 1g of peppermint reference medicine is prepared, and a reference medicine solution is prepared by the same method. Taking menthol reference substance, adding absolute ethanol to prepare a solution containing 2mg per 1ml, and taking the solution as reference substance solution. According to a thin layer chromatography (general rule 0502) test, sucking 5-10 μl of each of the above three solutions, respectively spotting on the same silica gel G thin layer plate, spreading with toluene-ethyl acetate (9:1) as developing agent, taking out, air drying, spraying with 40% sulfuric acid ethanol solution of 2% p-dimethylaminobenzaldehyde, heating at 80deg.C until the spots develop clearly, and placing under ultraviolet lamp (365 nm) for inspection. In the sample chromatogram, fluorescent spots with the same color appear at the positions corresponding to the control chromatogram and the control chromatogram.
(4) Taking 1g of the powder (crushed after drying fresh product), adding 10ml of chloroform, carrying out ultrasonic treatment for 20 minutes, and filtering to obtain filtrate as a test solution. And 1g of rhizoma phragmitis reference medicine is prepared into a reference medicine solution by the same method. According to a thin layer chromatography (general rule 0502) test, 10 μl of each of the above two solutions is absorbed and respectively spotted on the same silica gel G thin layer plate, petroleum ether (60-90 ℃) and ethyl formate (15:5) are used as developing agents, and the developing agents are developed, taken out, dried and sprayed with 10% sulfuric acid ethanol solution, heated at 110 ℃ until the spots develop clearly, and then detected under an ultraviolet lamp (365 nm). In the chromatogram of the test sample, fluorescent spots with the same color appear at the positions corresponding to the chromatogram of the control medicinal material.
(5) Taking 0.5g of the product powder, adding 10ml of ethanol, shaking for 5 minutes, filtering, evaporating filtrate to dryness, and adding 2ml of ethanol into residues to dissolve the residues to obtain a test solution. And adding ethanol into paeoniflorin reference substance to obtain a solution containing 2mg per 1ml, and taking the solution as reference substance solution. According to a thin layer chromatography (general rule 0502) test, 4 μl of each of the above two solutions is sucked and respectively spotted on the same silica gel G thin layer plate, chloroform-ethyl acetate-methanol-formic acid (40:5:10:0.2) is used as developing agent, developed, taken out, dried, sprayed with 5% vanillin sulfuric acid solution, and heated until the spots develop clearly. The same blue-violet spots appear on the sample chromatogram at the positions corresponding to the control chromatogram.
(6) Taking 2g of the product powder, adding 25ml of methanol, soaking for 1 hour, carrying out ultrasonic treatment for 30 minutes, filtering, evaporating the filtrate to dryness, adding 25ml of water into the residue to dissolve, carrying out shaking extraction for 2 times with water-saturated n-butanol for 30ml each time, combining n-butanol solutions, evaporating to dryness, and adding 5ml of methanol into the residue to dissolve to obtain a sample solution. 2g of radix scrophulariae is prepared as a control medicinal material, and the control medicinal material solution is prepared by the same method. And adding methanol into the harpagoside reference substance to prepare a solution with 1mg per 1ml serving as a reference substance solution. According to the thin layer chromatography (general rule 0502), 4 μl of each of the above three solutions is sucked and respectively spotted on the same silica gel G thin layer plate, the lower layer solution of chloroform-methanol-water (12:4:1) is used as developing agent, the developing agent is placed into a developing cylinder which is presaturated for 15 minutes, developed, taken out, dried, sprayed with 5% vanillin sulfuric acid solution, and hot air is blown until the spots develop clearly. In the sample chromatogram, spots with the same color appear at the positions corresponding to the control chromatogram and the control chromatogram.
[ MEANS FOR SOLVING ] measurement by high performance liquid chromatography (appendix VI D).
[ heavy metal examination ]
Taking 1g of the product, placing the product in a crucible, slowly burning the product until the product is completely carbonized, cooling the product to room temperature, adding 1ml of sulfuric acid to moisten the product, heating the product at a low temperature until sulfuric acid vapor is removed completely, cooling the product to room temperature, and checking that the product contains no more than twenty parts per million of heavy metals according to law (second method of appendix IX E of Chinese pharmacopoeia 2005 edition).
[ usage and dosage ]
The medicine is taken with boiled water 1 bag at a time and 3 times a day.
The invention is different from western medicine antibiotics, has the effects of clearing heat, relieving sore throat and resolving phlegm, does not generate drug resistance in clinical application, and has obvious advantages of treating acute and chronic pharyngitis, upper respiratory tract infection and bronchopneumonia; the invention is derived from the ancient prescription and proved prescription of Yi medicine for thousands of years, carries out addition, subtraction and chemical combination based on the basic treatment rules of Yi medicine ' cause and root cause control ' and the theory of Yi medicine ' upper method ' for treating pharyngitis, and selects the prescription of the medicine ' pterodontoseisis with characteristics of Yi medicine; the product can comprehensively and particularly and prominently solve the specimen problems of pharyngitis and cough, and has no toxic or side effect; as a Chinese medicine (Yi nationality medicine) preparation, the preparation is a product of the perfect combination of the essence of the national medicine and the modern pharmaceutical industry, has the effects of detoxification, relieving sore throat, removing blood stasis, dredging collaterals, relieving pain, cooling blood and nourishing yin, has good effects on the symptoms of pharyngitis and excessive syndrome and deficiency and excessive inclusion, can cooperate with antimicrobial, anti-inflammatory and antioxidant effects, improves local symptoms and reduces drug resistance caused by abuse of antibiotics. The product belongs to one of the first Yi medicine research and development conversion products of Sichuan province.
Test example 1
200 chronic pharyngitis patients are randomly divided into a treatment group and a control group, wherein 100 patients are treated by taking the medicament of the invention; 100 cases of control groups are treated by western medicines; the treatment course is 7 days. The efficacy evaluation results were as follows:
table 1. Data of curative effect of Yi medicine Jin Lingqing pharyngeal particles on treatment of chronic pharyngitis:
| cure rate (%) | Good conversion (%) | Total effective rate (%) | |
| Jin Lingqing throat granule | 34 | 64 | 98 |
| Antibiotics | 18 | 58 | 76 |
During observation, normal blood, urine and feces are observed, and abnormal changes and toxic and side effects are not found in safety observation of heart, liver, kidney functions and the like.
The results show that the invention has the effects of detoxification, sore throat relieving, stasis dispelling, vein relaxing, pain relieving, blood cooling and yin nourishing, has definite curative effect on chronic pharyngitis, is safe and reliable, is convenient to take, and is worthy of popularization and application.
Although embodiments of the present invention have been disclosed above, it is not limited to the details of the description and the embodiments, which are well suited to various fields of use, additional modifications may be readily made by those skilled in the art without departing from the general concept defined by the claims and their equivalents.
Claims (8)
1. The Yi medicine Jin Lingqing pharyngeal granules are characterized by comprising the following raw materials in parts by weight: 1.67-25.05 parts of honeysuckle (Yi nationality: also resistant to Yi nationality), 1.11-16.65 parts of pterodontoseisis (Yi nationality: bei Naipa), 1.11-16.65 parts of peppermint (Yi nationality: pacifica) 1.38-26.27 parts of reed rhizome (Yi nationality: suan ruyi), 13.72-34.92 parts of red peony (Yi nationality: yi QI Po ZU) and 13.72-34.92 parts of radix scrophulariae.
2. A method for preparing Yi medicine Jin Lingqing pharyngeal granules, which is characterized by comprising the following steps:
firstly, taking honeysuckle, laggera pterodonta, peppermint, reed rhizome, red paeony root and figwort root according to the mass parts, putting the honeysuckle, the laggera pterodonta, the peppermint, the reed rhizome, the red paeony root and the figwort root into a 1 ton extraction tank, adding 10 times of drinking water for the first time, soaking for 30 minutes, starting a reflux device to collect reflux liquid, keeping the liquid level slightly boiling after boiling, starting timing with the reflux of a first drop of reflux liquid, distilling medicinal materials for 30 minutes, and putting the reflux liquid into a closed container for standby; and (5) closing the reflux device for continuous decoction for 30 minutes, and filtering the liquid medicine by a 80-mesh screen for later use.
3. Adding 10 times of drinking water respectively for the second time and the third time, decocting for 60 minutes each time, filtering the decoction by a 80-mesh screen after the decoction is finished, and combining the three filtrates to be concentrated.
4. And thirdly, mixing the extracting solution extracted for three times and the reflux liquid, then sucking the mixture into a single-effect concentrator, controlling the vacuum degree to be- (0.075-0.085 Mpa), concentrating the mixture at the concentration temperature of 45-55 ℃ under reduced pressure, and concentrating the mixture into extractum with the relative density of 1.36-1.39 (50 ℃) for later use.
5. Step four, granulating: the sucrose is crushed by 80 meshes to obtain sucrose powder, 1 part of extract with qualified relative density, 1 part of dextrin and 4 parts of sucrose powder are weighed, the sucrose powder and the dextrin are poured into a groove type mixer and stirred for 3 minutes, the extract and purified water or 75% ethanol are added to prepare a proper soft material, and the soft material is granulated by a 14-mesh nylon net swing granulator.
6. And fifthly, putting the prepared wet particles into a fluidized bed dryer, setting the drying temperature to be 60 ℃ for drying, and taking out of the pot after the moisture of the particles is lower than 2.0%.
7. Step six, the dried granules are finished by a stainless steel screen mesh with 10 meshes and 28 meshes, qualified granules are obtained in the middle of 10 meshes to 28 meshes, and the qualified granules are put into a turnover barrel for standby.
8. And seventhly, subpackaging the qualified particles by using a blank coiled film with the specification of 140mm, wherein the packaging amount is controlled between 9.7 and 10.4g during subpackaging.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111490521.6A CN116270903A (en) | 2021-12-08 | 2021-12-08 | Yi medicine Jin Lingqing pharyngeal granules and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202111490521.6A CN116270903A (en) | 2021-12-08 | 2021-12-08 | Yi medicine Jin Lingqing pharyngeal granules and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116270903A true CN116270903A (en) | 2023-06-23 |
Family
ID=86829161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202111490521.6A Pending CN116270903A (en) | 2021-12-08 | 2021-12-08 | Yi medicine Jin Lingqing pharyngeal granules and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116270903A (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110538281A (en) * | 2019-09-27 | 2019-12-06 | 首都医科大学附属北京朝阳医院 | traditional Chinese medicine preparation for treating pharyngitis and tonsillitis, preparation method and application |
-
2021
- 2021-12-08 CN CN202111490521.6A patent/CN116270903A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110538281A (en) * | 2019-09-27 | 2019-12-06 | 首都医科大学附属北京朝阳医院 | traditional Chinese medicine preparation for treating pharyngitis and tonsillitis, preparation method and application |
Non-Patent Citations (2)
| Title |
|---|
| 侯妍: "中药雾化吸入治疗急慢性咽炎疗效观察", 中国校医, no. 02, 25 April 2001 (2001-04-25), pages 1 - 6 * |
| 董韶昱, 董彩霞: "金嗓利咽丸治疗慢性咽炎256例", 河南中医, no. 10, 10 October 2005 (2005-10-10), pages 57 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4147708A1 (en) | Traditional chinese medicine composition for treating novel coronavirus pneumonia, preparation method, detection method, and use thereof | |
| EP2512444B1 (en) | Mixtures of plants in spagyric mother tincture for dry cough in babies | |
| EP3821902B1 (en) | Traditional chinese medicine composition, traditional chinese medicine compound preparation and preparation method and use thereof | |
| Li | Chinese herbal medicine | |
| CN102920964B (en) | Traditional Chinese medicine preparation for curing cough | |
| CN105535533A (en) | Traditional Chinese medicine composition for treatinggastritis | |
| CN116270903A (en) | Yi medicine Jin Lingqing pharyngeal granules and preparation method thereof | |
| CN104524273A (en) | Preparation method of Yinqiao preparation | |
| CN106075229A (en) | A kind of Chinese medicinal composition preparation treating anemopyretic cold | |
| CN105169149A (en) | Traditional Chinese medicine composition for treating pyrophlegm stasis accumulation type thyroid cancer, preparation method and application | |
| CN107802676B (en) | Lilac extract and preparation method and application thereof | |
| CN112138058A (en) | Throat-moistening candy and preparation method and application thereof | |
| CN105435162B (en) | Traditional Chinese medicine composition for treating allergic rhinitis, preparation method and traditional Chinese medicine preparation | |
| CN111249421B (en) | Traditional Chinese medicine preparation for treating initial damp-heat exogenous fever as well as preparation method and application thereof | |
| CN1981809B (en) | Danshen effective component, its preparation, making method and usage | |
| CN116211805A (en) | Yi medicine clear lung-heat clearing granule and preparation method thereof | |
| CN105287863A (en) | Pharmaceutical composition for curing DN (Diabetic Nephropathy) and preparation method of pharmaceutical composition | |
| CN105477375A (en) | Traditional Chinese medicine composition for treating gastritis | |
| CN105497557A (en) | Preparation method for traditional Chinese medicine composition for treating gastritis and preparation | |
| WO2020098831A1 (en) | Gynecological qianjin capsule and quality control method therefor | |
| CN109106761A (en) | Fork divides the application of knotweed, fork branch knotweed and manyspike knotweed herb total extract and its elution position in preparation treatment ulcerative colitis drug | |
| CN1981811B (en) | Danshen effective component, its preparation, making method and usage | |
| CN111789891A (en) | Preparation method and application of traditional Chinese medicine ointment for treating eczema | |
| CN117323263A (en) | Traditional Chinese medicine extraction composition with relieving function and application thereof | |
| CN112891429A (en) | Mulberry and chrysanthemum granules capable of ventilating lung and relieving cough and preparation method of mulberry and chrysanthemum granules |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |